Primary Open Angle Glaucoma
Ophthalmology·MeSH: Glaucoma, Open-Angle
Prevalence
3000.0 / 100K
Incidence
150.0 / 100K/yr
4 drugs in development·3 companies·3 clinical trials
Drug Pipeline by Phase
Phase 2(1)
Preclinical(1)
| Drug | Company |
|---|---|
| man 01 | Q BioMed Inc. (QBIO) |
Compare drugs
Frequently asked questions
How many drugs are in development for Primary Open Angle Glaucoma?
BioSniper tracks 4 drugs in development for Primary Open Angle Glaucoma across 3 companies.
How many clinical trials target Primary Open Angle Glaucoma?
There are 3 clinical trials targeting Primary Open Angle Glaucoma tracked by BioSniper.
What is the prevalence of Primary Open Angle Glaucoma?
The estimated prevalence of Primary Open Angle Glaucoma is approximately 3000.0 per 100,000 population.
Deep-dive into Primary Open Angle Glaucoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis